TrovaGene Inc (TROV): Betting on a Test for the Human Papillomavirus (HPV) – SmallCap Network

TrovaGene Inc (TROV): Betting on a Test for the Human Papillomavirus (HPV)
SmallCap Network
Small cap TrovaGene Inc (NASDAQ: TROV) has developed a test for the Human Papillomavirus (HPV), the most common sexually transmitted virus in the United States, but there is more to this small cap than its HPV test. Moreover, TrovaGene has been a

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *